A PPD is performed for the detection of tuberculosis.  0.1cc of 5 units of Purified Protein Derivative is injected intradermally on the volar surface of the arm.  A 6-10 mm. wheal should be produced at the time of injection. 

Indications for Testing
1. Routine skin testing is not recommended for children in areas of low  TB prevalence 
2. Children in areas with high prevalence of TB but of with no other risk factors should be tested between the ages of  4-6 and 11-16 
3. Immediate testing should be performed 
   a. Contact with individuals suspected of having TB or has an infiltrate consistent with TB on chest radiograph 
   b. Radiograph suspicious of TB 
   c. Children who have come from Asia, the Middle East, Africa, and Latin America 
   d. Travel recently to a country where TB is endemic 
4. Annual Testing
   a. Child is HIV + or an HIV + individual lives in the house 
   b. Incarcerated adolescent 
5. Testing every 2-3 years
   a. Exposure to HIV + individuals, migrant workers, incarcerated individuals, nursing home residents, IV drug users, and homeless individuals. 

Interpretation of PPD
1. The test must be interpreted between 48-72 hours by an individual trained in evaluating PPD's.  Studies have shown that parental interpretation of PPD's have been inaccurate and almost 60% of PPD's placed are never read. 
2. The interpretation is based on the size of induration, not redness. 
3. A thorough history of the child,  family members, other household members, and prevalence in the community is important in the interpretation of the test. 

Positive Tests

> 5 mm
1.  Children in close contact with an active case of TB. 
2. Children suspected to have TB 
   a. + chest radiograph consistent with active disease or previously active disease 
   b. Clinically picture consistent with TB, i.e. meningitis 
3, Immunocompromised individuals, children on immunosuppressive drugs including high doses of steroids,  HIV +, or other immunosuppressed states 

> 10 mm
1. < 4 years old 
2. Diabetics, chronic renal disease, malnourished individuals, lymphoma, and Hodgkin's disease 
3. Child or their parents are born in endemic areas 
4. Exposure to HIV+ individuals, incarcerated or institutionalized persons, IV drug users, nursing home residents, and migrant workers. 
5. Travel to endemic areas 

> 15 mm
1. > 4 years old without any risk factors 

False Positives
1. Improper application of the test 
2. Cross reactivity with non-tuberculosis mycobacterium 

False Negatives
1. Within the incubation period of developing TB, 2-12 weeks 
2. Incorrect interpretation 
3. Disseminated disease 
4. Viral illness- measles, chicken pox, influenza, HIV 
5. T cell disease 
6. Steroids 
7. Malnutrition 
8. Chronic illnesses 
9. 5% of culture proven TB will have negative PPD. A negative PPD never excludes TB 

Interpretation of PPD Following BCG Administration
1. BCG is used in more than 100 countries and usually given at birth or shortly after.  It is derived from Mycobacterium bovis and is 50-80% protective against life threatening TB such as miliary and TB meningitis. It does not prevent infection with the bacteria. 
2. Some children who are administered BCG never have a positive PPD 
3. If PPD is positive, usually less than 10 mm 
4. + test usually persists 3-5 years after administration 
5. PPD should be administered to individuals with the same indications of non-BCG recipients.  Try to verify that the child had the BCG or check for scar that the administration of the vaccine produces. 
6. If greater than 10 mm of induration, a chest radiograph should be performed, and the necessity for chemotherapy evaluated.  A consultation with a TB specialist is recommended to decide whether to initiate anti-tuberculosis medications. 

Reference
1. The 2003 Redbook 
2. Abernathy RS. Tuberculosis: An Update. Pediatrics in Review. 1997; 18:50-58.
3. Committee on Infectious Diseases. Update on Tuberculosis Skin Testing of Children.  Pediatrics Vol.97 No. 2 February 1996.
4. Correa AG. Unique Aspects of Tuberculosis in the Pediatric Population. Clinics in Chest Medicine. 1997. 18(1):89-98.
5. Santiago E. A ProspectiveStudy of Bacillus Calmette-Guerin Scar Formation and Tuberculin skin Testist Reactivity in Infants in Lima, Peru.  Pediatrics. Vol 112 No. 4. October 2003
6. Nelson LJ. Epidemiology of Childhood Tuberculosis in the United States, 1993-2001: The Need for Continued Vigilance.  Pediatrics August 2004